Speaker illustration

Mrs Anne Carr

Hagersville (Canada)

Which treatment attributes do patients with transthyretin amyloid cardiomyopathy value most?

Event: Heart Failure 2025

Topic: Pharmacotherapy

Session: ePosters in chronic heart failure - pharmacotherapy (2)

Thumbnail